Avid Bioservices Inc (CDMO): At 200 events what might the Sunrise Dat...

Send PM Follow Ignore

Followers	27
Posts	3416
Boards Moderated	0
Alias Born	07/17/2006

pphmtoolong

Re: None

Tuesday, 03/17/2015 10:48:28 AM

Tuesday, March 17, 2015 10:48:28 AM

At 200 events what might the Sunrise Data Monitoring Committee see? If the Phase II study's results are predictive, I think they will see a 50 increase in MOS for the eventers. Roughly 8 months for non-Bavi arm patient and 12 months for Bavi arm patient - a 50% increase in Bavi survival time.

As we are talking about 200 events, this is many more patients than the statistically significant Phase II study's 120 patients. What would the DMC recommend?

I don't know when we will see the first look-in, but I think it will be sometime in the second half of this year. I don't know that the results will be as good as above, but I don't think such results would be a surprise.

I know we've been saying "soon" forever. I know we've heard this will be a great year for Peregrine before.

Maybe soon will be soon. Maybe this will be a great year for Peregrine.

We'll see.

GLTA, Paul